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ABSTRACT: The aim of this study was to evaluate maternal and
fetal lipid profile in intrauterine growth restriction (IUGR) pregnan-
cies with and without preeclampsia (PE). Thirteen normal pregnancies
studied during the third trimester (control M) and 29 at elective cesarean
section (control CS) were compared with 18 pregnancies complicated
by IUGR (IUGR only) and with seven pregnancies complicated by
both IUGR and PE (IUGR-PE). Total plasma fatty acids, triglycer-
ides, cholesterol, and nonesterified fatty acids (NEFA) were deter-
mined in maternal and fetal plasma. Nutritional intake was analyzed.
IUGR only mothers had lower percentage of linoleic acid (LA) and
higher arachidonic acid (AA) than controls, partly explained by
higher AA dietary intake. Higher levels of NEFA were observed both
in IUGR only and in IUGR-PE mothers whereas triglyceride levels
were increased in IUGR-PE mothers only. In IUGR-PE fetuses, LA
and AA were significantly decreased, whereas triglyceride and NEFA
concentrations were significantly increased compared with normal
fetuses. In conclusion, IUGR only is associated with altered fatty
acids profile not completely accounted by dietary changes. We
hypothesize that the differences observed in IUGR with PE for
triglycerides and other lipids could be related to a difference in
maternal phenotype. (Pediatr Res 64: 615–620, 2008)
Intrauterine growth restriction (IUGR) is characterized by adeficiency of fetal growth and a failure of the conceptus to
follow its growth potential. This condition is considered a
severe disease because it can be associated with adverse
outcomes during pregnancy, labor, and the neonatal period
(1–4). Moreover, shifts during perinatal growth have pro-
nounced effects on neonatal and adult health (5,6). In recent
years, a number of studies have reported a correlation among
low birth weight and cardiovascular and metabolic diseases
during adult age (7).
IUGR has been correlated to a specific placental phenotype
based on the evidence that defective fetal nutrition is related to
inadequate transport function (8). We have previously dem-
onstrated that placental supply of amino acids is reduced in
IUGR fetuses independently from the severity of growth restric-
tion and from the presence of hypoxia (9). Moreover, maternal-
fetal gradient of glucose are increased in severe IUGR fetuses,
i.e., those with alterations of umbilical blood flow (10).
The dietary essential fatty acids, linoleic (18:2 n-6, LA),
-linolenic (18:3 n-3, LNA), and their long chain polyunsatu-
rated derivatives (LCPUFA), mainly arachidonic acid (20:4 n-6,
AA) and docosahexaenoic acid (22:6 n-3, DHA), are impor-
tant structural elements of cell membranes, which are needed
for the normal development of the CNS and retina (11). We
have previously reported that IUGR fetuses studied in utero at
the time of fetal blood sampling are characterized by reduced
conversion ratios of LCPUFA from their derivatives (12).
Preeclampsia (PE) represents another important cause of
perinatal morbidity and mortality (13). The typical clinical
manifestations of PE, including hypertension, proteinuria, and
the varying degrees of ischemic peripheral organ damage,
which typically arise in the third trimester of gestation, might
represent late phenomena of the complex process of implan-
tation and placental formation (14).
Therefore, IUGR and PE might represent different aspects
of placental insufficiency caused by a deficient remodeling of
the spiral arteries during the interaction between maternal and
fetal sides at the time of trophoblast invasion (15,16).
Plasma concentrations of both triglyceride-rich lipoproteins
and nonesterified fatty acids (NEFA) are significantly in-
creased in women who develop PE relative to normal pregnant
women (17), contributing to the endothelial dysfunction of PE
by serving as substrates for lipid peroxidation with the gen-
eration of free radicals, lipid peroxides, and reactive oxygen
species (17–19). On the other hand, an unbalanced ratio
between tromboxane and prostacyclins, both derivatives of
AA, has been recognized as one of the steps leading to
placental hypoxia in pregnancy-induced hypertension (20).
Moreover, tromboxane and prostacyclins are also mediators ofReceived January 22, 2008; accepted July 12, 2008.
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the inflammatory process that have recently been involved in
the systemic impact of placental insufficiency (18–20).
In the present study, maternal and fetal total plasma fatty
acids have been compared in normal and IUGR pregnancies
evaluating the influence of maternal dietary intakes and the
potential differences in presence of PE.
METHODS
The studies were performed in the Unit of Obstetrics and Gynecology of
the DMCO San Paolo Hospital, Milan and in the Unit of Obstetrics and
Gynecology of the Clinica Mangiagalli, Milan, in a period of 4 y (October
2000–June 2005). The University of Milan Ethical Board approved the
protocol of the study. Informed consent was obtained from all pregnant
women.
Clinical studies. Forty-two normal pregnancies (controls) and 25 pregnan-
cies complicated by IUGR were studied. Gestational age was calculated from
the last menstrual period and confirmed by routine ultrasonography at 20 wk
of gestation. Exclusion criteria were maternal diseases, gestational diabetes,
alcohol abuse, drug addiction, abnormal fetal karyotype, and fetal malforma-
tions or infections. All pregnancies were singleton and none of the women
smoked during pregnancy.
Controls were normal pregnancies that delivered appropriate for gesta-
tional age birth weight infants according to Italian birth weight-gestational
age standards (21). Twenty-nine controls were studied at the time of elective
cesarean section (control CS) performed because of previous CS, breech
presentation, or maternal choice. Thirteen controls (control M) were sampled
during the third trimester at an average gestational age (33.6 2.1 wk) similar
to the timing of delivery for the IUGR group. These pregnancies were
followed until delivery to confirm normal birth weight at term and normal
pregnancy outcome.
IUGR was identified in utero as a reduction in fetal growth rate by
measurements of abdominal circumferences below the 10th percentile of
reference values for fetuses of similar ages or by a decrease of more than 40
percentiles from the growth curve (22). Growth restriction was confirmed at
birth if the neonatal weight was below the 10th percentile according to Italian
standards for birth weight and gestational age (21). All pregnancies compli-
cated by IUGR performed an elective CS in the interest of the fetus according
to our clinical protocol.
Table 1 summarizes the characteristics of the population. As expected,
IUGR only pregnancies were delivered at an average gestational age (34.1 
3.0 wk) significantly lower than for normal pregnancies (38.6  0.5 wk).
Therefore, IUGR only mothers were compared with controls of similar
gestational age (control M) whereas IUGR only fetuses were compared with
controls studied at CS (control CS). Birth weight and placental weight, as well
as gestational age at delivery were significantly lower in IUGR only compared
with both control groups.
Seven women with IUGR were also affected by preeclampsia (IUGR-PE)
defined by the presence of hypertension and proteinuria (23).
Maternal venous blood samples were obtained in all pregnancies after
overnight fasting. Time since last meal was always between 10 and 12 h. In
pregnancies studied at cesarean section (control CS and all IUGR), maternal
venous blood samples were obtained simultaneously with umbilical arterial
and venous blood samples collected from a doubly clamped segment of the
cord immediately after fetal extraction.
Pregnant women were interviewed with a nutritional questionnaire to
evaluate the characteristics of their diets and to calculate nutrient intakes. This
is a semiquantitative validated questionnaire composed of pictures of most
common Italian foods in different amounts (24). All pregnant women had to
indicate the frequency of every dish consumed during the month before
sampling. Data were entered in software designed for calculations of nutrient
quantities.
Biochemical analyses. Blood samples were collected in EDTA tubes and
kept on ice until centrifugation. Plasma for fatty acid analyses was separated
by centrifugation at 3000 rpm for 10 min at 4°C and frozen at 80°C until
analysis.
Lipids were extracted from 0.20 mL of plasma in chloroform/methanol
(2:1) containing 10 mg/L of BHT (25). Fatty acids were trans-esterified with
methanolic hydrochloride, and fatty acid-methyl esters were separated and
analyzed on a Perkin Elmer gas chromatograph (Autosystem; Norwalk, CT)
as previously reported (26). Total plasma fatty acids were expressed as
percentage (g/100g) of all detected fatty acids with a chain length of 12–24
carbon atoms in the sample. Plasma cholesterol, triglycerides, and free fatty
acids (NEFA) were determined by commercial kits (Spinreact, Gerona, Spain)
for cholesterol and triglycerides, and Wako Chemicals (GmbH, Neuss, Ger-
many) for NEFA.
Statistical analysis. Data are presented as mean  SD. The significance of
the differences between fatty acids in IUGR only, IUGR-PE, and control
groups was calculated with an unpaired t test and with a two factorial unvaried
ANOVA with Bonferroni posttest. Because NEFA did not follow a normal
distribution, we performed a Kruskall Wallis test with Bonferroni posttest.
They are represented as Median  inter quartile range. Differences between
fetal and maternal samples in control CS were calculated with a paired t test.
RESULTS
Nutritional questionnaire results. Nutritional information
was collected from normal and pathological pregnancies and
pooled results are presented in Table 2. Total daily caloric
intake, as well as total amount of proteins, carbohydrates, or
lipids were not significantly different among the groups. No
significant differences were obtained among different types of
lipids, except for the intake of AA, which was significantly
higher in IUGR compared with control pregnancies.
Comparison between maternal and fetal fatty acids in
normal pregnancies. Table 3 presents fatty acids in maternal
and umbilical venous plasma of control pregnancies at term
(control CS). The percentage of total saturated fatty acids was
significantly higher in fetal than in maternal plasma, the
difference corresponding to stearic acid (18:0) whereas
palmitic acid (16:0) was lower in fetal than in maternal
plasma. The proportion of oleic acid (18:1 n-9) was lower in
fetal than in maternal plasma, the difference in PUFA corre-
sponding to a lower proportion of LA (18:2 n-6) whereas both
AA and DHA were higher in the fetal side. These differences
Table 1. Characteristics of the studied population
Controls (n  42) IUGR (n  25)
Control CS (n  29) Control M (n  13) IUGR only (n  18) IUGR-PE (n  7)
Age (y) 32.0  5.2 31.6  4.3 32.7 4.2 34.3 4.7
BMI pre-pregnancy (kg/m2) 22.4  4.0 20.8  2.0 23.2 4.9 24.6 4.9*
Sampling (wk) 38.6  0.3 33.6  2.1† 34.6 2.4† 32.1 3.3*†‡
Delivery (wk) 38.6  0.3 38.5  1.7 34.6 2.4*† 32.1 3.3*†‡
Gender (M/F) 17/12 4/9 8/10 4/3
Neonatal weight (g) 3335.2 304.4 3246.1 328.6 1715.0 523.7*† 1284.3 399.2*†
Placental weight (g) 519.4 108.0 589.2 107.7 252.2 78.0*† 252.3 114.1*†
Data are expressed as mean SD. t test was used to determine differences between the groups: * p  0.05 vs control M, † p  0.05 vs control CS, ‡ p  0.05
vs IUGR only.
Control CS, physiologic pregnancies studied at cesarean section; control M, mothers with physiologic pregnancies studied during the third trimester of
pregnancy; IUGR only, pregnancies complicated by intra uterine growth restriction; IUGR-PE, pregnancies complicated by both IUGR and preeclampsia.
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are similar to those previously reported (27). Plasma concen-
trations of cholesterol, triglycerides, and NEFA were signifi-
cantly higher in control mothers than in the fetal compartment
(Table 4) with ratios of 5:1, 9:1, and 6:1, respectively. No
significant differences were observed between umbilical vein and
artery for these values (data not shown).
Comparison between IUGR and control mothers. Table 3
presents the percentage of total plasma fatty acids in the four
groups studied. The comparison between mothers at 34 wk
(control M) and mothers at CS showed differences only for
palmitic acid and the ratio between DHA and LNA that was
lower and for steric acid that was higher in control M than in
control CS.
Total plasma values of IUGR only mothers were compared
with controls of similar gestational age (control M). No
difference was found between the two groups for total satu-
rated fatty acids although there were some differences within
individual fatty acids. Palmitic acid (16:0) was higher in
IUGR only than in controls whereas stearic acid (18:0) was
lower in IUGR only than in control women.
Table 3. Total plasma fatty acids in maternal and umbilical venous plasma
Fatty acids g/100g Control CS n  29 Control M n  13 IUGR only n  18 IUGR-PE n  7
Saturated
m.v. 37.0 2.7 38.0 4.6 37.2  2.4 38.7 2.4
u.v. 50.5 5.4 46.0  7.0 53.9 3.5*
Polyunsaturated
m.v. 32.1 4.0 33.3 4.1 31.1  3.6 28.5 3.0
u.v. 26.6 3.4 27.5  2.5 24.4 1.7
Palmitic acid
m.v. 27.3 2.4 23.5 3.4† 28.8  2.5‡ 28.8 1.6‡
u.v. 25.2 5.6 28.0  3.6 28.8 4.4
Stearic acid
m.v. 7.0 2.7 9.5 2.8† 6.3  2.2‡ 7.2 2.0
u.v. 20.1 10.5 14.7  7.9 18.7 7.9
Oleic acid
m.v. 26.8 3.0 25.4 2.7 25.8  3.0 27.3 1.5
u.v. 19.5 2.6 20.0  4.0 17.3 3.3
LA
m.v. 22.5 4.2 24.1 4.3 19.7  3.1‡ 18.5 2.5‡
u.v. 7.9 1.6 8.6  1.7 7.2 1.0
LNA
m.v. 0.4 0.3 0.5 0.4 0.2  0.1 0.2 0.2
u.v. na na na
AA
m.v. 5.0 0.9 4.8 1.0 5.8  1.1‡ 5.1 0.9
u.v. 12.3 1.8 11.0  2.1 10.3 2.4†
EPA
m.v. 0.6 0.6 0.4 0.8 0.5  0.4 1.1 1.0
u.v. 1.2  2.4 0.9  1.4 1.9 1.8
DHA
m.v. 2.4 0.5 2.3 0.6 2.2  0.5 2.6 0.8
u.v. 4.0 0.9 3.8  0.6 4.3 1.5
AA/LA
m.v. 0.2 0.1 0.2 0.1 0.3  0.1†‡ 0.3 0.0
u.v. 1.7 0.4 1.3  0.3† 1.3 0.2
DHA/LNA
m.v. 6.8 2.6 3.7 2.0† 8.4  2.1†‡ 10.5 7.4†‡
u.v. na na na
Data are expressed as mean SD. Bonferroni’s posttest was used to determine differences between the four groups after the ANOVA test: * p 0.05 vs IUGR
only, † p  0.05 vs control CS, ‡ p  0.05 vs control M.
u.v. and m.v. are always significantly different except when u.v. is reported in italics.
EPA, eicosapenahenoic acid; m.v., maternal vein; u.v., umbilical vein; na, not available.






kcal 2175.1  608.3 1818.6  638.2
Proteins (g) 98.1 28.5 (17.5%) 87.0 24.7 (17.6%)
Carbohydrates (g) 324.1 93.1 (61.0%) 274.9 112.3 (60.4%)
Lipids (g) 60.9 21.8 (21.5%) 48.1 23.1 (22.0%)
Cholesterol (g) 272.2 121.2 228.9  84.2
Saturated fatty acids (g) 43.1 19.7 31.6  16.3
Monounsaturated fatty
acids (g)
16.7  7.9 15.1  9.2
Oleic acid (g) 3.3  1.6 2.5  1.5
Linoleic acid (g) 13.9 13.4 7.6  4.2
Linolenic acid (g) 1.3 0.5 1.1  0.6
Arachidonic acid (g) 0.08 0.06 0.16  0.13*
Eicosapentaenoic
acid (g)
0.10  0.14 0.11  0.13
Docosahexaenoic
acid (g)
0.08  0.10 0.04  0.02
Data are expressed as mean  SD, for proteins, carbohydrates, and lipids,
percentage of total caloric intake is indicated.
* p  0.05 IUGR vs controls.
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LA was significantly lower in IUGR only than in control
pregnancies whereas AA was higher, whereas no significant
differences were observed for 20:5 n-3 (EPA) or 22:6 n-3 (DHA).
The ratio between AA and LA (AA/LA) and between DHA
and LNA (DHA/LNA) were significantly higher in IUGR only
than in control mothers (Table 3).
As shown in Table 4, the concentration of NEFA in maternal
plasma was significantly higher in IUGR only than in gestational
age-matched controls (control M) with no significant differences
in the concentration of cholesterol or triglycerides.
Comparison between IUGR only and normal fetuses (con-
trol CS). Table 3 presents the comparison of umbilical vein
total plasma fatty acids between IUGR only and control CS.
No significant differences were found between the two groups
for any of the fatty acids, except for the AA/LA ratio, which
was significantly lower in IUGR than in control CS fetuses.
The fetal-maternal ratio was significantly higher for the per-
centage of LA (control CS  0.36  0.07; IUGR only 
0.43  0.10; p  0.01) and significantly lower for the
percentage of AA (control CS  2.49  0.46; IUGR only 
1.96  0.60; p  0.01) in IUGR only compared with normal
pregnancies (data not shown). Comparison between umbilical
and maternal plasma was similar to that observed in control
CS pregnancies for all other fatty acids (Table 3). No differ-
ences were observed for cholesterol, triglycerides, and NEFA
in umbilical venous plasma between IUGR only and controls
(Table 4).
Differences in IUGR with PE. Table 3 shows the compar-
ison between IUGR-PE and controls for maternal and fetal
fatty acid profiles. No differences were found for any of the
fatty acids between IUGR-PE and IUGR only in maternal or
umbilical venous plasma, except for a higher proportion of
saturated fatty acids in umbilical venous plasma in IUGR-PE
than in IUGR only. Some differences were found in the
comparison of maternal IUGR only and IUGR-PE plasma
with controls. Palmitic acid was significantly higher both in
IUGR only and IUGR-PE mothers than in their gestational
age-matched controls (control M). In the n-6 fatty acid family,
lower percentages of LA were found both in IUGR only and
IUGR-PE maternal plasma versus control M, whereas AA and
the ratio AA/LA were significantly higher only in IUGR only
than in control mothers (control M). In umbilical venous
plasma, the percentage of AA was significantly lower than in
controls (control CS) only in IUGR-PE, whereas the ratio
AA/LA was significantly lower only in IUGR only than in
controls. No difference between the IUGR and control groups
in maternal or umbilical venous plasma was found for any of
the fatty acids of the n-3 family (i.e., LNA or DHA) but
DHA/LNA had a higher ratio in both IUGR only and
IUGR-PE than in control mothers. NEFA concentrations were
significantly higher in both IUGR-PE and IUGR only mothers
than in controls (Table 4). In umbilical venous plasma, NEFA
concentrations were significantly higher only in IUGR-PE
versus controls. No significant difference was observed for
cholesterol. Triglyceride concentrations were significantly
higher in maternal plasma of IUGR-PE than in IUGR and in
controls (Table 4) whereas in umbilical plasma, triglycerides
were higher in IUGR-PE only versus controls (control CS).
Triglycerides, cholesterol, and NEFA had no relationship
with maternal age or BMI when all data were pooled together
or in the single groups of controls and IUGR (data not shown).
DISCUSSION
In the current study, we evaluated fatty acid profiles in
mothers and fetuses of pregnancies complicated by intrauter-
ine growth restriction. Furthermore, we evaluated whether the
concomitant presence of PE was associated with a different
maternal and/or fetal fatty acid phenotype.
In agreement with previous studies (11,12,27,28), we re-
ported higher percentages of LCPUFA (DHA and AA) and
lower percentages of their essential precursors (LNA and LA)
in fetal than in maternal plasma. This phenomenon has been
called “biomagnification” and has been related to the capabil-
ity of placenta and/or fetus to increase the percentages of
LCPUFA in the fetal circulation, i.e., to provide the fetus with
molecules that have been implied in CNS development in
physiological conditions (11).
Evaluation of dietary intakes by nutritional questionnaires
allowed to consider whether differences in plasma results were
Table 4. Lipids in maternal and umbilical venous plasma
Control CS (n  29) Control M (n  13) IUGR only (n  18) IUGR-PE (n  7)
Cholesterol (mg/dL)
m.v. 225.8 43.9 243.5  47.2 255.6  47.7 267.9  43.0
u.v. 44.6 18.1 67.9 32.5 59.7  31.0
Triglycerides (mg/dL)
m.v. 263.2 106.9 208.6  54.2 196.2  95.2 316.4  95.5*†
















Cholesterol and triglycerides are expressed as mean  SD. Bonferroni’s posttest was used to determine differences between the four groups after the ANOVA
test: * p  0.05 vs control M, ‡ p  0.05 vs control CS, † p  0.05 vs IUGR only.
NEFA are expressed as median (interquartile range). Bonferroni’s posttest was used to determine differences between the four groups after the Kruskal-Wallis
test. Different symbols in a row indicate differences (p  0.05).
m.v., maternal vein; u.v., umbilical vein.
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because of the differences in nutritional intakes between nor-
mal and IUGR pregnancies. Total caloric intakes, as well as
intake of total proteins, carbohydrates, and lipids were similar
in normal and IUGR mothers, except for a small, but signif-
icantly higher intake of AA in IUGR-complicated pregnancies
compared with controls. Nutritional sources of AA are seed
oils eggs, poultry, and pig meats (29). Although this nutri-
tional difference could contribute to the higher proportion of
AA found in maternal plasma of IUGR, its influence should be
small because of its small proportion in the diet and the fact
that the proportion of its synthetic precursor, LA, is much
higher than that of AA in both the diet and plasma.
Despite the evidence of higher AA in mothers, the fetal
fatty acid profile showed lower percentage of AA in fetal
plasma of IUGR with PE. This difference might be related to
inadequate placental function, similar to what was previously
reported for other nutrients in IUGR (8–10). Possible mech-
anism responsible for the altered LC-PUFA profile could be
changes in lipoprotein intake and degradation, and/or in fatty
acids binding proteins (30,31). A potential bias of these data is
related to the different gestational age at the time of CS in
IUGR compared with control pregnancies. However, we pre-
viously reported similar results in a smaller subset of IUGR
pregnancies studied at fetal blood sampling, with a control
group of comparable gestational age (12).
In the current study, we also report different fatty acid
profiles in mothers of IUGR with or without PE. Mothers with
IUGR only presented lower percentages of the n-6 essential
fatty acid LA associated with higher percentages of AA than
controls of similar gestational age. This led to a higher ratio of
AA/LA in IUGR only mothers. In pregnancies complicated by
both IUGR and PE (IUGR-PE), AA was not significantly
higher than in controls despite significantly lower percentage
LA. Although this might be simply related to the failure to
reach statistical power, another possible speculation is related
to the increased arachidonic employment in the synthesis of
molecules liable to the pathogenesis of PE, such as thrombox-
ane (32). PE and IUGR are two pathological conditions
involving an inflammatory process probably beginning in the
placenta during the first stages of pregnancy (16). Several
mediators of inflammation (prostaglandins, leucotrienes, and
thromboxane) are derived from AA. From our data, we there-
fore hypothesize that increased availability of AA, (significant
in IUGR; not significant in IUGR-PE) might lead to the
production of inflammatory mediators (33).
We also observed a higher n-3 ratio of DHA/LNA both in
IUGR and IUGR-PE mothers than in controls (control M)
without any significant difference in the fetal compartment.
This result is difficult to explain. The proportion of the fetal
DHA is not significantly different in IUGR, but the level of
LNA is very low and usually not detectable, therefore, it was
not possible to calculate a conversion ratio for n-3 in the fetus.
Interestingly we also found significant differences in mater-
nal plasma NEFA and triglycerides but not in cholesterol
levels. Increased levels of NEFA are associated with increased
maternal lipolysis in the last trimester of normal pregnancies
(27,34). We here report significantly higher NEFA levels in
maternal plasma of IUGR only and in IUGR-PE mothers. This
could be because of the increased adipose tissue lipolytic
activity enhanced by the pathological stressing condition
(35,36) although decreased glycerol production has been re-
cently reported in women carrying IUGR fetuses (37).
PE is a condition historically associated with hyperlipid-
emia and most of all hypertriglyceridemia (38) that is involved
in the vascular damage typical of this syndrome (39): women
with higher plasma lipid or triglyceride levels are at higher
risk of hypertensive disorders and stroke due to atherosis (18)
and in the same way they are exposed, in younger age, to
higher risks of PE (38). Although cholesterol levels did not
change, we observed higher levels of triglycerides in maternal
plasma only of IUGR-PE and not of IUGR only. Differences
in BMI should not account for this result, since no relationship
was observed between triglycerides and BMI in our popula-
tion. Previous studies have already reported increased levels
of triglycerides in PE (40,41) and triglycerides related vascu-
lopathy and the inflammation cascade typical of PE (39)
recognize the lipoperoxidation of fatty acids as one etiologic
factor (42).
Increases of NEFA and triglycerides in the fetal circulation
of only IUGR-PE could be the reflection of changes in pla-
cental lipase activities (31–43) in this pathological condition
characterized by placental insufficiency but also by a vascular
damage in which the atherogenic role of lipids and lipoper-
oxidation have been well established (18).
In summary, these results demonstrate that fatty acid pro-
files and plasma lipids are significantly altered in both mater-
nal and fetal circulation of IUGR pregnancies, Moreover, a
specific maternal and fetal fatty acid phenotype is demon-
strated in IUGR pregnancies associated with PE. Because this
is an observational study, the role of maternal, placental, and
fetal factors in determining these differences needs to be
further investigated.
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